IRON Financial’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$239K Sell
3,822
-127
-3% -$8.03K 0.1% 123
2026
Q2
$228K Buy
3,949
+258
+7% +$14.8K 0.09% 141
2026
Q1
$224K Buy
+3,691
New +$215K 0.1% 127
2024
Q3
– Sell
-13,870
Closed -$576K – 110
2024
Q2
$576K Buy
13,870
+340
+3% +$15.2K 0.32% 56
2024
Q1
$734K Buy
13,530
+3,060
+29% +$156K 0.41% 46
2023
Q4
$537K Sell
10,470
-509
-5% -$26.7K 0.3% 56
2023
Q3
$637K Buy
10,979
+926
+9% +$56.7K 0.37% 49
2023
Q2
$643K Sell
10,053
-70
-0.7% -$4.69K 0.35% 53
2023
Q1
$702K Buy
+10,123
New +$714K 0.39% 50

Other funds holding BMY

IRON Financial's BMY Position: Q3 2026 in Review

IRON Financial reduced its Bristol-Myers Squibb (BMY) stake by 3.2% in Q3 2026, selling an estimated $8.03K and leaving 3,822 shares worth $239K. The position accounts for 0.1% of the portfolio, ranked #123.

IRON Financial first reported a position in BMY in Q1 2023 and has held it in 9 quarters since. The position peaked at $734K in Q1 2024. 2,569 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • IRON Financial held 3,822 shares of Bristol-Myers Squibb worth $239K as of Q3 2026.
  • IRON Financial sold 127 Bristol-Myers Squibb shares in Q3 2026, an estimated $8.03K.
  • Bristol-Myers Squibb made up 0.1% of IRON Financial's portfolio in Q3 2026, its #123 holding.
  • IRON Financial first reported a position in Bristol-Myers Squibb in Q1 2023 and has held it in 9 quarters since.
  • IRON Financial's Bristol-Myers Squibb position peaked at $734K in Q1 2024.
  • 2,569 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on IRON Financial's 13F filing for Q3 2026, filed 23 Oct 2026.